Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease

NCT00004488 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.

NCT NCT00004488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Phase
Phase 2
Overall status
Completed
Start date
October 31, 1998
Completion date
September 30, 2002
Enrollment
82 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

gaucher's disease, osteopenia